2004
DOI: 10.1038/sj.bmt.1704566
|View full text |Cite
|
Sign up to set email alerts
|

Antirecipient helper and cytotoxic T-cell frequencies in bone marrow transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…Quantification of the allogeneic CTL response in vitro was obtained by the CTLp assay (6), because it has been proven to be clinically relevant in predicting allogeneic HSCT outcome (7)(8)(9)(10)(11)(12)(13). These studies focused on the amino acid differences on those parts of MHC class I molecules that are important for TCR contact and/or peptide binding.…”
mentioning
confidence: 99%
“…Quantification of the allogeneic CTL response in vitro was obtained by the CTLp assay (6), because it has been proven to be clinically relevant in predicting allogeneic HSCT outcome (7)(8)(9)(10)(11)(12)(13). These studies focused on the amino acid differences on those parts of MHC class I molecules that are important for TCR contact and/or peptide binding.…”
mentioning
confidence: 99%
“…Multiple publications have reported that the CTLp frequency assay is able to predict clinical outcome of HCT ( 7 , 19 21 ), which is the reason why this assay is incorporated in the clinical decision making of donor selection in several Dutch transplant centers ( 6 ). The CTLp assay quantifies the frequency of donor CTLp’s capable of responding to mismatched HLA Class I antigens presented on the recipient’s cells.…”
Section: Discussionmentioning
confidence: 99%
“…, 1997; Van der Meer et al. , 2000; Kwok et al. , 2004) and are also indicative of HLA antigenic variants (Barnardo et al.…”
Section: Introductionmentioning
confidence: 99%
“…High host-specific pretransplant cytotoxic T-lymphocyte precursor (CTLp) frequencies can be detected in patients developing acute GvHD after unrelated HLA-matched bone marrow transplantation (Kaminski et al, 1989;Schwarer et al, 1994;Spencer et al, 1995;Keever-Taylor et al, 1997;Van der Meer et al, 2000;Kwok et al, 2004) and are also indicative of HLA antigenic variants (Barnardo et al, 1996;Speiser et al, 1996;Scott et al, 1998;Van der Meer et al, 2000). Also, high host-reactive donor helper T-lymphocyte precursor (HTLp) frequencies have been shown to be associated with the incidence and severity of acute GvHD and to detect mismatches in HLA class II (Schwarer et al, 1994;Potolicchio et al, 1996;Keever-Taylor et al, 1997;Russel et al, 2001;Kwok et al, 2004) and even HLA class I antigens (Schwarer et al, 1994;Keever-Taylor et al, 1997). However, other studies suggest that determination of host-reactive donor CTLp and HTLp frequencies is not predictive for the development of acute GvHD (Fussel et al, 1994;Montagna et al, 1996;Pei et al, 1997).…”
Section: Introductionmentioning
confidence: 99%